;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Banker tracks

    Dresner Partners hired Robert Friedman as managing director, healthcare. Friedman was most recently managing director at Northeast Securities, and previously co-head of healthcare investment banking for Burnham …

    Published on 11/21/2014
  • FINANCIAL NEWS: Lexicon raises $130M in follow-on and notes

    Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) raised $80 million through the sale of senior convertible notes and $50 million in a follow-on through the sale of 49.8 million shares at $1. JP Morgan; Goldman Sachs; Needham;…

    Published on 11/21/2014
  • FINANCIAL NEWS: BioNano raises $53M in series C

    BioNano Genomics Inc. (San Diego, Calif.) raised $53 million in an untranched series C round led by new investors Legend Capital and Novartis Venture Fund. Other new investors included Federated Kaufmann Fund and …

    Published on 11/20/2014
  • FINANCIAL NEWS: Celsus planning $46M follow-on

    Inflammation and dermatology play Celsus Therapeutics plc (NASDAQ:CLTX) intends to raise up to $46 million in a follow-on underwritten by Cowen; Piper Jaffray; and MTS. The offering will comprise American Depositary …

    Published on 11/20/2014
  • FINANCIAL NEWS: EyeGate downsizes proposed IPO

    Ophthalmology company EyeGate Pharmaceuticals Inc. (Waltham, Mass.) amended terms for its proposed IPO on NASDAQ underwritten by Aegis Capital Corp. The company now plans to sell 1.4 million shares at $6-$8. At $7, …

    Published on 11/20/2014
  • FINANCIAL NEWS: Neothetics loses ground after $65.1M IPO

    Neothetics Inc. (NASDAQ:NEOT) fell $2 (14%) to $12 in its first day of trading on Thursday after it raised $65.1 million through the sale of 4.7 million shares at $14 in an IPO. The deal valued Neothetics at $190.7 …

    Published on 11/20/2014
  • FINANCIAL NEWS: Rockwell dips after $58.5M follow-on

    Rockwell Medical Inc. (NASDAQ:RMTI) lost $0.90 to $8.91 on Thursday after it raised $58.5 million through the sale of 6.5 million shares at $9 in a follow-on underwritten by BofA Merrill Lynch; Stifel; Summer Street; …

    Published on 11/20/2014
  • FINANCIAL NEWS: Trevena planning $40M follow-on

    Neurology company Trevena Inc. (NASDAQ:TRVN) proposed to raise $40 million in a follow-on underwritten by Barclays; Cowen; Jefferies; JMP; and Needham.Trevena is developing GPCR ligands that activate or block specific …

    Published on 11/20/2014
  • FINANCIAL NEWS: Amicus raises $90 million on back of Amigal

    Amicus Therapeutics Inc. (NASDAQ:FOLD) raised $90 million to commercialize its Amigal migalastat to treat Fabry's disease after pricing a follow-on of 13.9 million shares at $6.50 per share on Wednesday. Amicus intends …

    Published on 11/19/2014
  • FINANCIAL NEWS: Baird closes oversubscribed Fund IV at $185M

    Baird Capital closed its fourth venture fund, BVP IV, at $185 million, exceeding its target of $150 million. The firm invests in technology and healthcare companies, with an emphasis on medical devices and diagnostics.…

    Published on 11/19/2014
  • FINANCIAL NEWS: N30 raises $30 million

    N30 Pharmaceuticals Inc. (Boulder, Colo.) raised $30 million in a mezzanine financing. New investors included Wellington; RA Capital; Jennison; Rock Springs; and Sabby. Existing investor Deerfield also participated. …

    Published on 11/19/2014
  • FINANCIAL NEWS: Receptos rises after $360M offering

    Receptos Inc. (NASDAQ:RCPT) gained $4.97 to $107.95 Wednesday after it raised $360 million through the sale of 3.6 million shares at $100 in a follow-on underwritten by Credit Suisse; Leerink; Evercore; BMO; Wedbush …

    Published on 11/19/2014
  • FINANCIAL NEWS: Bellicum files for IPO

    Bellicum Pharmaceuticals Inc. (Houston, Texas) filed to raise up to $115 million in an IPO on NASDAQ underwritten by Jefferies; Citigroup; and Piper Jaffray. The company is conducting multiple Phase I/II trials of BPX-…

    Published on 11/18/2014
  • FINANCIAL NEWS: Juno IPO promises academic paydays

    Cancer immunotherapy developer Juno Therapeutics Inc. (Seattle, Wash.) will be obligated to pay two of its academic collaborators up to $525 million if its stock price exceeds certain thresholds within 11 years of its …

    Published on 11/18/2014
  • FINANCIAL NEWS: Onxeo proposes EUR 35.4M rights offering

    Orphan cancer company Onxeo S.A. (Euronext:ONXEO) proposed to raise EUR 35.4 million ($44.1 million) in a rights offering underwritten by Natixis and Oddo & Cie. The company plans to issue 7.9 million shares at EUR 4.50…

    Published on 11/18/2014
  • FINANCIAL NEWS: Amicus planning $75M follow-on

    Amicus Therapeutics Inc. (NASDAQ:FOLD) said it plans to raise $75 million in a follow-on underwritten by JPMorgan; Cowen; Leerink; and Janney Montgomery Scott. The company is planning to commercialize globally its …

    Published on 11/17/2014
  • FINANCIAL NEWS: Receptos proposes $325M follow-on

    Receptos Inc. (NASDAQ:RCPT) said it plans to raise $325 million in a follow-on underwritten by Credit Suisse; Leerink; Evercore; BMO; Wedbush; and Nomura. In two prior follow-ons this year, Receptos raised $117.4 …

    Published on 11/17/2014
  • FINANCIAL NEWS: Rockwell proposes to raise $55 million

    Rockwell Medical Inc. (NASDAQ:RMTI) proposed to raise $55 million in a follow-on underwritten by BofA Merrill Lynch; Stifel, Nicolaus; Summer Street; Craig-Hallum Capital Group; Chardan Capital; and LifeSci Capital.On …

    Published on 11/17/2014
  • FINANCIAL NEWS: BeiGene raises RMB450 million

    BeiGene Co. Ltd. (Beijing, China) raised a RMB450 million ($73.6 million) in a series A round. New investors Hillhouse Capital; CITIC Capital Partners; and an undisclosed public investment fund specializing in life …

    Published on 11/14/2014
  • FINANCIAL NEWS: FibroGen surges after upsized IPO

    FibroGen Inc. (NASDAQ:FGEN) closed up $4 (22%) to $22 on its first day of trading after raising $145.8 million through the sale of 8.1 million shares at $18 in an IPO on NASDAQ. AstraZeneca plc (LSE:AZN; NYSE:AZN) …

    Published on 11/14/2014
  • FINANCIAL NEWS: Histogenics sets IPO terms

    Histogenics Corp. (Waltham, Mass.) set terms for its IPO on NASDAQ and now plans to sell 4.3 million shares at $13-$15. At the midpoint, Histogenics would raise $60 million and be valued at $151.1 million. Cowen; …

    Published on 11/14/2014
  • FINANCIAL NEWS: NeuroDerm takes haircut, raises $45M in IPO

    Neurology play NeuroDerm Ltd.(NASDAQ:NDRM) dipped $0.85 to $9.15 on Friday in its first day of trading after it raised $45 million through the sale of 4.5 million shares at $10 in its IPO on NASDAQ. The price valued …

    Published on 11/14/2014
  • FINANCIAL NEWS: Capnia prices $10.7M IPO

    Capnia Inc. (NASDAQ:CAPN) lost $2.62 (40%) to $3.88 in its first day of trading Thursday after it raised $10.7 million through the sale of 1.7 million units at $6.50 in its IPO on NASDAQ. Each unit comprises a share and…

    Published on 11/13/2014
  • FINANCIAL NEWS: Gilead raises $4B in note deal

    Gilead Sciences Inc. (NASDAQ:GILD) raised $4 billion through the sale of senior unsecured notes underwritten by Merrill Lynch; JPMorgan; Barclays; and HSBC.The notes consist of $500 million in 2.1% notes due 2020, $1.75…

    Published on 11/13/2014
  • FINANCIAL NEWS: PRA Health raises $306M in IPO

    PRA Health Sciences Inc. (NASDAQ:PRAH) gained $1.62 to $19.62 in its first day of trading on Thursday after it raised $306 million via the sale of 17 million shares at $18 in an IPO on NASDAQ. The price valued PRA at $1…

    Published on 11/13/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993